Butterfly Network

Butterfly Network R&D / Revenue

The R&D to Revenue Ratio of Butterfly Network (BFLY) as of Nov 16, 2026 is 37.15 %. In the previous year, R&D to Revenue Ratio was 46.07 % — a change of -19.36% (lower).

R&D / Revenue

37.15 %

YoY

-19.36%

Last updated:

R&D to Revenue Ratio of Butterfly Network is 2025 37.15 % . R&D to Revenue Ratio of Butterfly Network was 2024 46.07 % . It decreases by -19.36% lower compared to the previous year.

The Butterfly Network R&D / Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D / Revenue
Date
R&D / Revenue
Jan 1, 2018
2,290.56 USD
Jan 1, 2019
177.41 USD
Jan 1, 2020
107.54 USD
Jan 1, 2021
119.01 USD
Jan 1, 2022
119.97 USD
Jan 1, 2023
84.39 USD
Jan 1, 2024
46.07 USD
Jan 1, 2025
37.15 USD
The Butterfly Network R&D / Revenue history
YEARR&D / RevenueYoY
37.15 %-19.36%
46.07 %-45.42%
84.39 %-29.65%
119.97 %+0.80%
119.01 %+10.67%
107.54 %-39.38%
177.41 %-92.25%
2,290.56 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Butterfly Network Stock analysis

What does Butterfly Network do? Butterfly Network, Inc. generates revenue through its medical imaging device portfolio, including the Butterfly iQ and iQ+ probes, which leverage Ultrasound-on-Chip technology for real-time 3D imaging. The company offers software subscriptions and the Butterfly Blueprint platform, which integrates Compass software into healthcare systems' clinical and administrative infrastructure. Healthcare systems purchase these products to deploy Butterfly iQ+ devices, while cloud-based software solutions and teleguidance services support remote management of health conditions. The Butterfly Academy provides in-app educational tutorials and formal education programs for clinical staff. Butterfly Network's revenue streams include hardware sales of the handheld ultrasound system, recurring software subscriptions for Compass and Butterfly Blueprint, and additional services like teleguidance and clinical support. Healthcare systems, particularly those seeking cost-effective imaging solutions, are the primary buyers of the Butterfly iQ+ and related software. The company's product ecosystem combines hardware, software, and educational services to address remote healthcare needs globally. The firm monetizes its proprietary Ultrasound-on-Chip technology through a combination of device sales, software subscriptions, and value-added services. Healthcare systems adopt Butterfly iQ+ for its affordability and portability, while the Butterfly Blueprint platform enables seamless integration into existing clinical workflows. Educational offerings via Butterfly Academy further enhance customer retention and system adoption across global healthcare providers. Butterfly Network is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Butterfly Network stock

R&D to Revenue Ratio of Butterfly Network is 37.15 % in 2025.

R&D to Revenue Ratio of Butterfly Network changed from 46.07 % to 37.15 %, representing a -19.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D to Revenue Ratio Butterfly Network since 2006 – with annual values, charts, and detailed analysis.

The R&D to Revenue ratio shows what percentage of revenue a company invests in research and development. Higher ratios indicate stronger focus on innovation.

A 'good' varies by industry and company stage. On Eulerpool, you can compare R&D to Revenue Ratio's Butterfly Network with sector peers and the industry average to assess whether it is attractive.

To evaluate R&D to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for R&D to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Butterfly Network

All Key Metrics — Butterfly Network